Share ownership Shenzhen YHLO Biotech Co., Ltd.

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 12/02/2026			5-day change	1st Jan Change
13.73 ^CNY	+0.44%		-5.51%	-3.31%

01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT

Share class: Shenzhen YHLO Biotech Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	570,267,400	242,006,601 ( 42.44 %)	0	42.44 %

Major shareholders: Shenzhen YHLO Biotech Co., Ltd.

Name	Equities	%	Valuation
Kun Hui Hu 44.1 %	251,500,100	44.1 %	523 M ¥
Ningbo Pengrui Enterprise Management Partnership LP 2.823 %	16,101,467	2.823 %	33 M ¥
Shenzhen Yingfu Huizhi Private Equity Fund Co. Ltd. 2.672 %	15,239,087	2.672 %	32 M ¥
Jiaxing Ruiyao Equity Investment LP 2.241 %	12,780,804	2.241 %	27 M ¥
Hwabao WP Fund Management Co., Ltd. 2.002 %	11,418,521	2.002 %	24 M ¥
Hainan Shuofeng Private Equity Fund Management Pp LP 1.972 %	11,247,147	1.972 %	23 M ¥
Ningbo Junhui Enterprise Management Partnership LP 1.736 %	9,898,000	1.736 %	21 M ¥
Yi Yu Yao 1.176 %	6,706,400	1.176 %	14 M ¥
LAV Management Co., Ltd. 1.062 %	6,054,869	1.062 %	13 M ¥
China Merchants Fund Management Co., Ltd. 0.9084 %	5,180,317	0.9084 %	11 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	45.28%
Other	11.44%
Institutional	8.89%
Unknown	34.39%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	45.28%
China	20.33%

Based on 1000 largest holdings

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Employees

1,678

Sector

Medical Equipment, Supplies & Distribution

Calendar

04-26 - Q1 2026 Earnings Release (Projected)

More about the company